ArticleSmall science2024
In-Foam Bioprinting: An Embedded Bioprinting Technique with Self-Removable Support Bath.
Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Aspiration-assisted bioprinting of spheroids.Nature protocols · 2026Review
- Unconventional bioprinting modalities for advanced tissue biofabrication.Biomaterials · 2026Review
- Cryobioprinted human tumor models with shelf-stable programmability.Trends in biotechnology · 2026Article
- Head and Neck 3D Bioprinting-A Review on Recent Advancements in Soft Tissue 3D Bioprinting and Medical Applications.Journal of functional biomaterials · 2025Review
- Personalized bioceramic grafts for craniomaxillofacial bone regeneration.International journal of oral science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of embedded three-dimensional (3D) bioprinting has revolutionized the biofabrication of free-form constructs out of low-viscosity and slow-crosslinking hydrogels. Using gel-based support baths has limitations including lack of proper oxygenation and nutrition and complications with bath removal. Herein, a novel-embedded 3D bioprinting technique is developed with an albumin foam support bath as a promising substitute. The proposed technique, in-foam bioprinting, offers excellent printability and convenience in bath removal while providing cells with easy access to oxygen and nutrients. The foam-based support bath is characterized through foam stability and rheological tests. The bubble size in the foam is measured to study the change in the structure of the bath due to the coalescence of the bubbles over time. Free-form structures are successfully 3D printed with thermoresponsive chitosan-based bioinks to demonstrate the capability of the in-foam bioprinting technique. The viability of bioprinted fibroblast L929 cells is studied over a seven-day period, showing high cell viability of over 97%, which is attributed to the abundance of oxygen and nutrition in the foam support bath. Importantly, in-foam bioprinting is beneficial for biofabricating large samples with a long printing time without jeopardizing cell viability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.